0001181431-13-018836.txt : 20130326 0001181431-13-018836.hdr.sgml : 20130326 20130326163314 ACCESSION NUMBER: 0001181431-13-018836 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130320 FILED AS OF DATE: 20130326 DATE AS OF CHANGE: 20130326 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001356576 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 1550 E GUDE DR CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-838-2500 MAIL ADDRESS: STREET 1: 1550 E GUDE DR CITY: ROCKVILLE STATE: MD ZIP: 20850 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BIGHAM MICHAEL CENTRAL INDEX KEY: 0001216917 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35518 FILM NUMBER: 13717227 MAIL ADDRESS: STREET 1: 890 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 rrd375105.xml X0306 4 2013-03-20 0 0001356576 SUPERNUS PHARMACEUTICALS INC SUPN 0001216917 BIGHAM MICHAEL C/O ABINGWORTH MANAGEMENT INC 890 WINTER STREET, SUITE 150 WALTHAM MA 02451 1 0 0 0 Common Stock 2013-03-20 4 P 0 5000 5.172 A 5000 I By Beatrice Emerson Bigham Trust U/A DTD 2/28/2001 Common Stock 2013-03-20 4 P 0 5000 5.195 A 5000 I By Cabot Forbes Bigham Trust U/A DTD 10/11/1996 Common Stock 2013-03-20 4 P 0 10000 5.264 A 10000 I By Michael F Bigham CRUT U/A DTD 11/23/1994 Common Stock 2013-03-22 4 P 0 15000 5.653 A 25000 I By Michael F Bigham CRUT U/A DTD 11/23/1994 Director Stock Option (Right to Buy) 7.90 2014-02-05 2023-02-05 Common Stock 8722 8722 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.11 to $5.20, inclusive. The Reporting Person undertakes to provide to any security holder of Supernus Pharmaceuticals Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) through (4). The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.17 to 5.20, inclusive. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.18 to 5.49, inclusive. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.53 to 5.68, inclusive. /s/ Gregory S. Patrick, as attorney-in-fact 2013-03-26